Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 8:40 pm Purchase |
2025-04-04 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 13,358,164 27.100% |
845,220 (+6.75%) |
Filing History |
| 2025-04-02 8:37 pm Purchase |
2025-03-31 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 12,512,944 25.400% |
533,846 (+4.46%) |
Filing History |
| 2025-03-03 7:07 pm Purchase |
2025-02-27 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 11,979,098 24.300% |
1,184,768 (+10.98%) |
Filing History |
| 2025-02-10 8:46 pm Purchase |
2025-02-06 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 11,560,350 40.200% |
6,481,034 (+127.60%) |
Filing History |
| 2025-01-28 8:07 pm Purchase |
2025-01-27 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 57,848,357 24.500% |
15,789,474 (+37.54%) |
Filing History |
| 2024-11-21 8:05 pm Purchase |
2024-11-19 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 42,058,883 19.100% |
75,000 (+0.18%) |
Filing History |
| 2024-11-14 5:09 pm Purchase |
2024-09-30 | 13G | Serina Therapeutics, Inc. SER |
BROADWOOD PARTNERS LP | 187,871 2.100% |
187,871 (New Position) |
Filing History |
| 2024-04-15 7:26 pm Purchase |
2024-04-11 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 5,079,316 37.600% |
5,079,316 (New Position) |
Filing History |
| 2024-02-08 6:57 pm Purchase |
2024-02-06 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 41,983,883 22.200% |
6,756,610 (+19.18%) |
Filing History |
| 2024-01-10 5:23 pm Purchase |
2024-01-04 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 10,794,330 22.100% |
665,586 (+6.57%) |
Filing History |
| 2023-11-15 5:27 pm Purchase |
2023-11-09 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 10,128,744 20.700% |
633,121 (+6.67%) |
Filing History |
| 2023-10-10 08:00 am Purchase |
2023-10-04 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 9,495,623 19.600% |
877,716 (+10.18%) |
Filing History |
| 2023-04-07 10:38 am Purchase |
2023-04-03 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 2,856,559 33.300% |
1,345,914 (+89.10%) |
Filing History |
| 2022-07-28 5:06 pm Purchase |
2022-07-21 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 1,510,645 24.100% |
321,897 (+27.08%) |
Filing History |
| 2022-04-15 5:21 pm Purchase |
2022-04-13 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 1,188,748 19.990% |
296,969 (+33.30%) |
Filing History |
| 2022-03-25 5:23 pm Purchase |
2022-03-10 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 35,227,273 20.700% |
980,106 (+2.86%) |
Filing History |
| 2021-10-01 4:59 pm Sale |
2021-10-01 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 8,617,907 18.200% |
-408,350 (-4.52%) |
Filing History |
| 2021-09-24 4:40 pm Unchanged |
2021-09-23 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 891,780 19.300% |
0 (Unchanged) |
Filing History |
| 2021-06-15 8:46 pm Sale |
2021-06-14 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 9,026,257 19.200% |
-443,734 (-4.69%) |
Filing History |
| 2021-04-05 5:12 pm Sale |
2021-04-01 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 9,469,991 20.300% |
-455,931 (-4.59%) |
Filing History |